Community services are under growing strain, with more than 1.1 million people waiting for care, and the steepest rise among ...

The size of the community care waiting list for children has increased by 58% since data began in 2022, compared with a 23% increase for adults, according to a new briefing on growing waits for ...

“There are some positive signs in today’s findings, with the number of social care jobs continuing to increase and vacancies ...

The government has been locked in a dispute with pharmaceutical companies for a number of months over how much the NHS pays ...

Sarah Scobie responds to the news of a six-month review of the GP funding formula. Responding to a six-month review of the GP funding formula, set to be announced today by Minister of State Stephen ...

The seismic changes to the relationship with our nearest neighbours and the impact of Brexit have only added fuel to the fire of severe challenges facing health and social care in the UK today, making ...

This research draws on an extensive literature review to assess the realism of the narrative that moving care out of hospital will save money. It explores five key areas: elective care, urgent and ...

Articles in this series were created in the run-up to the 2024 general election. The information in this briefing is still relevant when thinking about ways to improve health and care. The NHS and ...

Responding to reports that the government is considering raising the NICE threshold for the maximum that pharmaceutical companies can charge for new medicines, Nuffield Trust Senior Policy Analyst, ...

Responding to the announcement of a new NHS ‘online hospital’, Dr Becks Fisher said: “Bringing digital care approaches together through a new ‘online hospital’ is an interesting experiment. This will ...

Moving care ‘from hospital to home’ is one of the three major shifts the government has chosen as priorities to turn the NHS around. It carries the promise of better experience for patients and less ...

Huseyin Naci is an Associate Professor in the Department of Health Policy at the London School of Economics and Political Science (LSE). He is the Director of the Pharmaceutical Policy Lab.